BM Theatre Limited
Unaudited Financial Statements
For the year ended 31 January 2025
Pages for Filing with Registrar
Company Registration No. 09835176 (England and Wales)
BM Theatre Limited
Company Information
Directors
M Byam Shaw
N Salmon
S Newman
R Ramus
Secretary
K Barraball
Company number
09835176
Registered office
39-41 Charing Cross Road
London
WC2H 0AR
Accountants
Moore Kingston Smith LLP
Charlotte Building
17 Gresse Street
London
W1T 1QL
BM Theatre Limited
Contents
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
BM Theatre Limited
Balance Sheet
As at 31 January 2025
Page 1
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
3
1
1
Current assets
Debtors
5
10,917
32
Cash at bank and in hand
22,872
8,748
33,789
8,780
Creditors: amounts falling due within one year
6
(33,788)
(8,779)
Net current assets
1
1
Net assets
2
2
Capital and reserves
-
-
Called up share capital
7
2
2

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 3 December 2025 and are signed on its behalf by:
N Salmon
Director
Company Registration No. 09835176
BM Theatre Limited
Statement of Changes in Equity
For the year ended 31 January 2025
Page 2
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 February 2023
2
(12,947)
(12,945)
Year ended 31 January 2024:
Profit and total comprehensive income for the year
-
12,947
12,947
Balance at 31 January 2024
2
-
0
2
Year ended 31 January 2025:
Profit and total comprehensive income for the year
-
-
0
-
0
Balance at 31 January 2025
2
-
0
2
BM Theatre Limited
Notes to the Financial Statements
For the year ended 31 January 2025
Page 3
1
Accounting policies
Company information

BM Theatre Limited is a private company limited by shares incorporated in England and Wales. The registered office is 39-41 Charing Cross Road, London, England, WC2H 0AR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The accounts have been prepared on a basis other than a going concern, as the company is in process of being wound up and will not continue in operation. Assets and liabilities are stated at amounts expected to be realised or settled.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

Turnover represents the amount receivable for costs recharged net of VAT.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

BM Theatre Limited
Notes to the Financial Statements (Continued)
For the year ended 31 January 2025
1
Accounting policies
(Continued)
Page 4
1.6
Financial instruments

The company only has basic financial instruments measured at amortised cost, with no financial instruments classified as other, or basic financial instruments measured at fair value.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons employed by the company during the year was nil (2024: nil).

3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
1
1
4
Subsidiaries

These financial statements are separate company financial statements for 31 January 2025.

Details of the company's subsidiaries at 31 January 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
BM UK Productions Limited
39-41 Charing Cross Road, London, England, WC2H 0AR
Ordinary
100.00
-
BM London Productions Limited
39-41 Charing Cross Road, London, England, WC2H 0AR
Ordinary
0
100.00
BM Theatre Limited
Notes to the Financial Statements (Continued)
For the year ended 31 January 2025
Page 5
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
217
32
Prepayments and accrued income
10,700
-
0
10,917
32
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,302
192
Amounts due to group undertakings
21,574
8,587
Accruals and deferred income
10,912
-
0
33,788
8,779
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary share of £1 each
2
2
2
2

Both of the ordinary shares have full rights in the company relation to voting, dividends and distributions.

8
Related party transactions

The company has taken the exemption under Section 33 Related Party Disclosures paragraph 33.1A from disclosing transactions with other members of a wholly owned group.

 

9
Parent company

There is no single ultimate controlling party.

 

2025-01-312024-02-01falsefalsefalse03 December 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityM Byam ShawN SalmonS NewmanR RamusK Barraball098351762024-02-012025-01-3109835176bus:Director12024-02-012025-01-3109835176bus:Director22024-02-012025-01-3109835176bus:Director32024-02-012025-01-3109835176bus:Director42024-02-012025-01-3109835176bus:CompanySecretary12024-02-012025-01-3109835176bus:RegisteredOffice2024-02-012025-01-31098351762025-01-31098351762024-01-3109835176core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3109835176core:CurrentFinancialInstrumentscore:WithinOneYear2024-01-3109835176core:CurrentFinancialInstruments2025-01-3109835176core:CurrentFinancialInstruments2024-01-3109835176core:ShareCapital2025-01-3109835176core:ShareCapital2024-01-3109835176core:ShareCapital2023-01-3109835176core:RetainedEarningsAccumulatedLosses2023-01-3109835176core:RetainedEarningsAccumulatedLosses2024-01-3109835176core:RetainedEarningsAccumulatedLosses2025-01-3109835176core:ShareCapitalOrdinaryShareClass12025-01-3109835176core:ShareCapitalOrdinaryShareClass12024-01-3109835176core:RetainedEarningsAccumulatedLosses2023-02-012024-01-31098351762023-02-012024-01-3109835176core:RetainedEarningsAccumulatedLosses2024-02-012025-01-3109835176core:Subsidiary12024-02-012025-01-3109835176core:Subsidiary22024-02-012025-01-3109835176core:Subsidiary112024-02-012025-01-3109835176core:Subsidiary222024-02-012025-01-3109835176bus:OrdinaryShareClass12024-02-012025-01-3109835176bus:OrdinaryShareClass12025-01-3109835176bus:OrdinaryShareClass12024-01-3109835176bus:PrivateLimitedCompanyLtd2024-02-012025-01-3109835176bus:FRS1022024-02-012025-01-3109835176bus:AuditExemptWithAccountantsReport2024-02-012025-01-3109835176bus:SmallCompaniesRegimeForAccounts2024-02-012025-01-3109835176bus:FullAccounts2024-02-012025-01-31xbrli:purexbrli:sharesiso4217:GBP